Overview

With a favorable business environment, Kazakhstan attracts foreign medicinal products and medical device manufacturers to invest in the region. To access the region, manufacturers must obtain market approvals from the National Center of Drugs, Medical Products and Medical Equipment Examination. Apart from growing demand towards domestic pharmaceutical production, Regulatory procedural challenges for registrations and licensing may affect product/device’s time-to-market.

Having a good understanding on Kazakhstan’s Regulatory regime, Freyr offers Regulatory affairs consulting support in the region to ensure manufacturers easily access the market with end-to-end compliance. Freyr’s Regulatory services in Kazakhstan span across:

  • Medical Devices
  • Drugs
  • OTC 

Freyr Capabilities

  • Strategic Regulatory Consulting
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • Dossier Management
  • Renewals and variations
  • Artwork and Labelling

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase – MOH
  • Regulatory team with proven global RA expertise
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines